Antibodies are an important part of the immune system and are specialized proteins, which help the human body to fight infections against harmful pathogens. They form an important part of the chapter in Class 12, Human Health and Disease in Biology. This article provides information on antibody structure and function, outlining their different types, mechanisms, and importance within the body for immune responses.
Latest: NEET 2024 Paper Analysis and Answer Key
Don't Miss: Most scoring concepts for NEET | NEET papers with solutions
New: NEET Syllabus 2025 for Physics, Chemistry, Biology
NEET Important PYQ & Solutions: Physics | Chemistry | Biology | NEET PYQ's (2015-24)
Antibodies are specialized proteins produced by the immune system to identify and neutralize foreign substances like bacteria and viruses. They bind specifically to antigens, marking them for destruction by other immune cells.
Antibodies, called immunoglobulins too, are Y-shaped proteins made by the body's immune system or B cells to help fight off diseases so that people do not get sick again with things they have already had before. immunoglobulin function by finding out what is harmful without harming healthy cells - they find out where things should not be then go ahead to kill them making sure we are safe at all times. Immunoglobulin (Ig) is the general term for these Y-shaped proteins produced by B cells. It can refer to the protein whether it's attached to a B cell (as a receptor) or free in the blood.
Also Read:
The immune system uses antibodies for two main purposes - they identify antigens, and they alert other immune cells.
Since an antibody attaches itself to a harmful object, such as a virus, thereby identifying it as prey for macrophages or T-cells, among others, this action helps other parts of the immune system destroy dangerous foreign organisms.
In fighting harmful invaders, the immune system needs to target them accurately and kill them effectively, which remains impossible without the help of such interactions.
The five functions of antibodies in the immune system are:
To understand how antibodies function in the immune system it’s important to know the structure of antibody molecule. Their polypeptide chains and particular regions having been joined together create a distinctive Y-shape they use for finding and rendering harmless harmful substances called antigens.
Antibody structure ncert explains that the antibodies consist of four polypeptide chains, these chains are specifically two heavy chains and two light chains, the chains are held together by disulphide bonds so that they form a y-shaped structure.
The heavy chains are bigger polypeptides, which make up the antibody structure’s main section.
Every single heavy chain includes a variable area located at its peak as well as an unchanging part, occupying all other parts of this chain.
This IgG, IgA, IgM, IgE, or IgD determines the class of an antibody, such as the effector actions entailed in the latter while being present throughout its lifespan, which is determined by this consistent area.
Light chains are small polypeptides that are attached to heavyweight chains, thus, two types exist; kappa (κ) and lambda (λ) which play similar roles in the binding of antigens. Each of these also comprises a variable portion and a constant fragment.
Antibodies contain regions for variable (V) and constant (C) sections which respectively perform different roles within the operation of antibodies.
Located at the ends of the Y-shaped structure are the variable regions, which are constituted by heavy and light chains.
It is these regions that distinguish them from one another in terms of specificity and allow them to attach to particular antigens.
The differences in amino acid sequences are what make variability possible in these areas leading to the production of an individualized distinctive antigen-binding site in them.
The point in the body where the antibody joins to the antigen is made up of the different regions on the heavy and light chains on the variable parts. That part of the antibody interacts physically with the antigen as it recognizes and binds to specific molecular structures The wide range of antibodies produced by the immune system can specifically bind to many different antigens thanks to such a high degree of diversity.
The rest of the antibody structure is composed of constant regions. In the heavy chains, the class of the antibody (IgG, IgA, IgM, IgE, or IgD) is determined by the constant region and the region is what enables effector functions e.g. binding to cell surface receptors and complement activation.
Determining the biological activity of the antibody, the constant regions are influential. For example, IgG antibodies protect a fetus by passing through a placenta, while IgA antibodies protect mucosal surfaces. Interactions between other immune system components such as phagocytes, and natural killer cells enhancing immune reactions involving the whole body also take place owing it this same region.
Antibody Diagram
Here's the labelled diagram of antibody molecule:
There are five main different types of antibodies, namely IgG, IgA, IgM, IgE and IgD into which antibodies, sometimes referred to as immunoglobulins fall. Each of these types has its attributes and is located in different parts of the body whereby they perform different tasks during an immune response.
Here is the description of antibody types and functions:
Antibody Type | Concentration in Blood | Main Functions | Primary Locations |
IgG | 75-80% | Long-term immunity, neutralizing toxins, opsonization | Blood, extracellular fluid, crosses the placenta |
IgA | 10-15% | Mucosal immunity, preventing pathogen attachment | Mucous membranes, saliva, tears, breast milk, gut, respiratory tract |
IgM | 5-10% | Initial immune response, forming antigen-antibody complexes | Blood, lymphatic fluid |
IgE | <1% | Mediating allergic reactions, defending against parasites | Lungs, skin, mucous membranes |
IgD | <1% | Initiating and regulating immune responses | Blood, surface of B cells |
In the blood and extracellular fluids, IgG is the most common kind of antibody, accounting for roughly 75-80% of all antibodies in the human body.
The most important function of IgG is in protecting an individual against repeated infections due to pathogens, it provides long-term immunity and immune memory.
Its importance lies in its ability to neutralize toxins, tag pathogens for destruction by phagocytes (this process is called opsonization) and activate complement by all three pathways.
IgG antibodies, which are mainly found in the blood and extracellular fluid can cross the placenta to give the fetus passive immunity.
Immunoglobulin structure type A is about 10-15 per cent of all antibodies present in the body.
Its main role in this respect is safeguarding the body surfaces exposed to outside elements, i.e. mucosal immunity where its primary function is preventing pathogens from attaching themselves onto epithelial cells found lining various body cavities such as the respiratory tract or intestines, among other places.
These are present in secretions like mucus, such as sweat or tears and also on the mucosa lining the gut and airways.
IgM exists as one of the first categories of antibodies produced by the body when infections are detected.
This first type constitutes about 5-10 per cent of all antibodies present in the organism.
It acts mostly at its primary levels of defence against pathogen-causing agents by quickly forming immune complexes and initiating complement system activation through different pathways.
IgM can be predominantly located within blood vessels or in lymphatic vessels/fluids.
IgE’s effect is great, although it exists at low levels within the circulating blood.
It is associated with allergic responses and fights off parasites.
It combines with antigens to stimulate the secretion of histamine from mast cells or basophils that cause allergy symptoms.
It is present in the lungs, skin and mucosa.
IgD is the least known antibody and it comprises a small proportion of those present in the body.
It is primarily found on the surface of those who have not been exposed to immunogens.
Thus, its function is largely associated with triggering and controlling the immune system.
Besides being present in small quantities within blood bloodstream, IgDs are also attached to those B-cell outer membranes.
The process of the production of antibodies is given below:
The onset of activation starts with the interaction of various antigens (foreign substances) which then trigger a response from white blood cells called B-lymphocytes.
Clonal selection is a vital process that ensures that the immune response discriminates highly against the invading pathogen.
Antibodies work to make sure pathogens are removed and destroyed using different methods.
When antibodies attach to pathogens, they counteract them and keep them from contacting cells in the same organism. This inhibits viruses and bacteria from going into and attacking cells, ensuring they do not cause harm.
Pathogens are covered in antibodies during opsonisation. So phagocytes like macrophage cells or white blood cells known as neutrophils can then destroy them. The Fc region of an antibody binds to Fc receptors that are located on phagocytes and therefore boosts the uptake and destruction of pathogens.
Once antibodies attach to pathogens (such as bacteria), the first step is to trigger the activation process of a group of proteins termed complement to get them lysed by them. This process kicks in when the proteins bond to antigens in what is referred to as the classical pathway for complement activation.
When antibodies join with antigens on the pathogens they stick the different pathogens together hence leading to agglutination i.e. clamping of pathogens. This makes it simpler for the phagocytes to decipher pathogens which makes them be removed easily from the body. The process by which antibodies join with pathogens in the process called agglutination which is known as clamping.
Antibodies in ADCC draw natural killer cells to destroy infected and malignant cells, with the antibody’s Fab region binding the antigen on the target cell and the Fc region binding it to Fc receptors on NK cells.
Epitope: The part of an antigen that is recognized and bound by an antibody or immune cell receptor. It's a small, specific region on the pathogen.
Paratope: The part of an antibody or immune receptor that binds to the epitope. It is specifically shaped to match the epitope, enabling a precise fit.
Antigens and antibodies, addressing different roles in immune defence mechanisms, are core body immunity elements. Knowing their differences is important if one hopes to understand how the body protects itself against harmful microbes.
Feature | Antigen | Antibody |
Definition | Substances that induce an immune response | Proteins produced in response to antigens |
Structure | Proteins, polysaccharides, or lipids | Y-shaped proteins with variable and constant regions |
Function | Initiate immune response | Bind specifically to antigens, neutralise, and mark for destruction |
Location | Found on pathogens or foreign substances | Produced by B cells, circulate in blood and body fluids |
Interaction | Recognised by immune cells | Bind to antigens to facilitate immune response |
There are numerous applications where antibodies are useful in diagnostics as well as treatment methods thereby serving as very useful instruments in today’s health sector. Their effectiveness arises from the fact that they attach themselves only to certain types of infections thus ensuring accurate scanning for particular illnesses before conveying necessary medications to infected areas.
In various diagnostic tests, antibodies are important for detecting the existence of particular antigens that are linked to diseases.
ELISA is a frequently used test in scientific laboratories where it detects antigens through antibodies with relative ease. Its applications such as identifying viral proteins or antibodies against them from a patient’s circulating serum make it possible to diagnose diseases like hepatitis B virus infection, and AIDS and HIV infection among others.
Rapid antigen tests are utilized for identifying pathogens in point-of-care surroundings rapidly. They are crucial for the following reasons, especially in COVID-19 Testing: detecting SARS-CoV-2 antigens by using nasal or throat swabbing as well as checking if you have flu infection through the performance of rapid tests targeting viral protein in nasal or throat swabs.
The treatment of some diseases has been improved greatly by monoclonal antibodies (mAbs) that allow for directing the therapy with a lot of precision.
Monoclonal antibodies specifically target cancer cells and do not damage normal cells such as Rituximab (Rituxan) targets CD20 on B cells: It is the key element used to cure non-Hodgkin's lymphoma as well as chronic lymphocytic leukaemia.
Monoclonal antibodies help to control the immune system in cases of autoimmune diseases. Used for the treatment of Crohn's disease or multiple sclerosis, Natalizumab, which is Tysabri, stops the migration of white blood cells to the brain.
Additionally, monoclonal antibodies can be used to treat infectious illnesses. Palivizumab (Synagis) is used to treat the infection of respiratory syncytial virus in high-risk infants, for instance.
The diagram shows the monoclonal antibodies that are used in targeting cancer cells. They bind to a specific receptor located at the surface of such cells.
The development of new treatments has been completely changed by antibody engineering technology. The making of monoclonal antibodies and boosting of antibody properties are some of the achievements in this field.
Monoclonal antibodies are derived from a single clone of B cells. These antibodies are designed in such a way that they can attach themselves specifically to one type of antigen, hence offering targeted therapy for different diseases.
The treatment landscape has been revolutionised for many illnesses with the intervention of monoclonal antibodies since they are highly efficient and specific.
Advances in genetic engineering have made antibodies more specific, with stronger bonds between antibodies and antigens. This resulted in the development of improved therapeutic modalities in the form of next-generation antibodies.
In phage display, bacteriophages (viruses that infect bacteria) are applied to target antigens to change the antibodies with high specificity. Phages are hung with the genes of the antibodies, which are then selected.
Bispecific antibodies are custom-made to attach two dissimilar antigens concurrently, so they can lock on two different targets or get two different cells to touch each other, e.g., T cells can contact tumour cells.
Antibodies provides resistance to various pathogens and disease:
Antibody-based treatments’ efficacy could be compromised when pathogens become resistant to them, as is common with antibiotics-resistant pathogens due to mutations that occur.
Mechanisms of Resistance: Pathogens can escape antibody detection by altering their surface antigens or developing ways to break down and hide from antibodies.
Combatting Resistance: Methods of overcoming resistance include using combinations of antibodies that target various antigens, making antibodies that get conserved areas less susceptible to mutation, and applying next-generation sequencing to quickly detect and respond to new strains of resistant organisms.
At times, antibody therapies can elicit autoimmune reactions, in which the immune system of an organism mistakenly assaults its cells or tissues.
Mechanisms: Autoimmunity could happen because a few cure antibodies will be able to cause reactions when they come into contact with human tissue or else mess up the body's natural defences.
Mitigation Strategies: In order to lower the chances of autoimmunity, there are three things that scientists do. They are making the specificity of antibodies better, carrying out preclinical trials carefully, and watching patients for adverse reactions. Another way to decrease immunogenicity is through humanising monoclonal antibodies.
Also Read:
Viral Disease | Bacterial Disease |
Protozoan Disease | Life Cycle of Plasmodium |
Immunity and Immune System | Difference between humoral and Cell Mediated Immunity |
Functions of IgG
IgG antibodies give advantage of long-term protection against many different agents such as bacteria, viruses, and bacterial toxins.
IgG is found to be one of the most potent complement activators when taken in respect to all other antibodies.
The binding ability of IgG to antigens is more specifically effective because of the reason that it enhances phagocytosis.
IgE is the major antibody that plays a role in many allergic reactions where it binds to reintroduced antigens and focuses on the release of pharmacologically active agents. It also helps to show response to allergens and antigen preparation that is helpful in desensitization immunotherapy.
IgA is found to be the first line of defense due to the reason that it protects the body from the entry and infection of mucosal surfaces by different foreign particles.
Antibody is made up of variable regions and a constant region. The variable region is called so because it changes to various structures totally dependent upon the differences in the antigen. The constant region is called so because it cannot change its shape according to the antigen. These two chains are responsible for making the structure of antibodies.
Monoclonal antibodies are a group of antibodies that are identical and are produced by a single clone of B cells. These cells act by simply binding to one definite antigen on its epitope. This feature has made them very useful in modern medicine, where they are used to provide highly specific treatments for diseases like cancer, autoimmune disorders and various infections.
Alteration of surface antigens by pathogens leads to therapy resistance as a result of versions in their surface protein structure or the development of means to dodge these antibodies. Measures to be taken here entail multiple antibody combinations targeting conserved areas less susceptible to mutation as well as fast recognition and response to additional resistant strains in any system through next-generation sequencing.
Antibodies, or immunoglobulins(Ig) are classified based on their H chains. IgG, IgM, IgA, IgD and IgE. There are five types of immunoglobulins.
An antibody, also known as an immunoglobulin, is a protein released by the immune system with the aim of identifying and neutralizing foreign substances including bacteria and viruses. In order to neutralize antigens, it selectively binds to them.
Emil von Behring and Kitasato Shibasaburō found the antibodies at the very end of the 1890s. As they had discovered some substances, to be located within blood, neutralizing toxins, it opened a way for understanding immunity responses and more generally, antibodies.
The five functions of antibodies in the immune system are:
Neutralization: Antibodies bind to pathogens (like viruses and bacteria) or toxins, blocking their ability to enter and infect cells.
Opsonization: By coating pathogens, antibodies make them easier for immune cells like macrophages to recognize and engulf, promoting phagocytosis.
Activation of the Complement System: Antibodies trigger the complement cascade, a series of proteins that help destroy pathogens through cell lysis and inflammation.
Agglutination: Antibodies bind to multiple pathogens, clumping them together to prevent their spread and make them easier to clear by immune cells.
Antibody-Dependent Cellular Cytotoxicity (ADCC): Antibodies mark infected cells, allowing natural killer (NK) cells to recognize and destroy these cells directly.
13 Nov'24 07:17 PM
13 Nov'24 05:08 PM
12 Nov'24 03:37 PM
12 Nov'24 01:07 PM
11 Nov'24 06:10 PM
10 Nov'24 07:48 PM
08 Nov'24 04:15 PM
06 Nov'24 08:32 AM
05 Nov'24 02:16 PM